Journal Article Summary
The article investigates the effects of norepinephrine reuptake inhibition using atomoxetine on patients with postural tachycardia syndrome (POTS), a condition characterized by an abnormal increase in heart rate upon standing. POTS can significantly impact daily functioning and is often associated with other conditions like ADHD and depression, which are treated with medications that may exacerbate POTS symptoms. Understanding how these medications affect heart rate and overall symptom burden in POTS patients is crucial for improving their management and quality of life.
In this study, 27 patients diagnosed with POTS participated in a randomized, crossover trial where they received either atomoxetine or a placebo on separate days. The researchers measured heart rate, blood pressure, and self-reported symptoms before and after taking the medication. The results showed that atomoxetine significantly increased standing heart rate and worsened the overall symptom burden compared to the placebo, indicating that this medication may not be suitable for POTS patients due to its potential to exacerbate their condition.
The study has some limitations, including the lack of detailed assessments of sympathetic nervous system activity before and after treatment, which could provide more insight into the physiological changes observed. Additionally, the trial was short-term, and further research is needed to evaluate the long-term effects and safety of norepinephrine reuptake inhibitors in POTS patients. Readers should consult with healthcare professionals before considering any medication, especially those that may affect heart rate and symptoms in individuals with POTS, to ensure safe and effective treatment options.
Medication Safety Note
This journal article summary is provided for educational purposes only and is not medical advice. Always consult a licensed healthcare professional before starting, stopping, or changing any medication.
Article Cited
- Green Elizabeth A., Raj Vidya, Shibao Cyndya A., Biaggioni Italo, Black Bonnie K., Dupont William D., Robertson David, Raj Satish R.. Effects of Norepinephrine Reuptake Inhibition on Postural Tachycardia Syndrome. Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease 2013. DOI: 10.1161/JAHA.113.000395. PMID: 24002370. PMCID: PMC3835251.
Featured Pill Pals Product
Atomoxetine 60 mg Capsules --- Generic for Strattera --- Glenmark
Atomoxetine 60 mg Capsules — Generic for Strattera — Glenmark is available through Pill Pals Pharmacy with cash-pay pharmacy pricing and free shipping where available. Prescription required.
Request a prescription transfer and our pharmacy team will help coordinate the next step.
